Instalab
logoInstalab

REMS T-Score (Right Femur)

Check for silent bone thinning in your right hip with radiation-free ultrasound.

Should you take a REMS T-Score (Right Femur) test?

This test is most useful if any of these apply to you.

Going Through or Past Menopause
Changing hormones can speed bone loss. This ultrasound estimate may add to an assessment of your hip density and fracture risk.
Concerned After a Low-Trauma Fracture
A break after a minor fall warrants a bone-health assessment, even if your scan result looks reassuring.
Taking Steroids for Months
Long-term steroid treatment can weaken bone. Bone-density testing helps inform a prevention or treatment plan.
Finding It Hard to Access a DXA Scan
Portable ultrasound can make bone assessment easier when travel or mobility is difficult, though DXA may still be needed.

About REMS T-Score (Right Femur)

Bone loss usually causes no symptoms until a fracture occurs. REMS uses ultrasound to estimate bone density in your right hip, offering a way to assess bone without ionizing radiation.

REMS is an emerging clinical method with published fracture-prediction studies. Its agreement with the established DXA bone-density scan varies across populations and clinical settings. Your result can contribute to a fracture-risk assessment, but it cannot establish how close you are to breaking a hip.

How the Scan Reads Your Hip

REMS stands for Radiofrequency Echographic Multi Spectrometry. A probe sends sound waves into the upper thigh bone and records the returning echoes. Software compares their patterns with reference data, incorporating age, sex, body size, and the skeletal site to estimate bone mineral density.

The femoral neck is the short section connecting the ball of the hip joint to the thigh bone. Much of the research on REMS hip measurements concerns this region. A total-hip measurement covers a larger area, so femoral-neck and total-hip results should remain separate when comparing scans.

The hip T-score expresses how far the estimated density lies from a young-adult reference average. More negative values indicate lower estimated density. The reference is based on young-adult women and is used for both women and men; the demographic information used to estimate density serves a separate purpose.

Right and left hips often give similar results. In a Mexican study with 455 women included in the analysis, REMS classifications agreed between the two femoral necks 97.4% of the time. That finding supports frequent agreement between sides, but an injury, operation, or condition affecting one hip can make the other hip different.

Fracture Risk

Lower REMS hip scores have been associated with subsequent fractures. The largest studies enrolled women, so their findings apply most directly to women resembling those study populations. A fragility fracture usually follows a fall from standing height or another low-energy injury.

Who Was StudiedWhat Was ComparedWhat the Finding Supports
Women followed for up to five years; 1,370 completed follow-upFemoral-neck REMS classifications in an age-matched analysis of 525 womenWomen classified as having osteoporosis had about 2.8 times the odds of a subsequent fragility fracture. The corresponding DXA association was similar.
About 4,300 women in a European multicenter studyREMS and DXA femoral-neck measurements in women with and without previous fracturesREMS distinguished these groups somewhat better in this cross-sectional comparison, which did not test prediction of future fractures.
A prospective cohort with 4,017 women completing follow-up, including 2,714 with femoral-neck assessmentsSeven categories combining the REMS T-score and Fragility ScoreHip-fracture frequency increased across the combined categories. Adding the Fragility Score improved discrimination within this cohort.

These findings support an association between the score and fracture risk. They do not establish that REMS is superior to DXA for predicting hip fractures or that using REMS to guide treatment prevents more fractures. Age, previous fractures, falls, and medications also affect risk, including when bone density appears reassuring.

The Fragility Score on Your Report

The Fragility Score is a separate REMS result derived from ultrasound patterns associated with skeletal fragility. It is intended to add information beyond estimated density. It should not be read as a direct measurement of microscopic bone structure or as your personal percentage chance of a fracture.

The prospective study described above supports combining this score with the T-score in women. It did not establish that the combination should replace FRAX or DXA-based treatment assessment. A disagreement between density and the Fragility Score deserves interpretation alongside your fracture history and other risk factors.

Why Hip Density Can Fall

Aging and the fall in estrogen after menopause contribute to bone loss. Low body weight, some diseases, and certain medicines can add to it. These are established influences on bone health, although a REMS result alone cannot identify which one explains your density.

Portable scanning can make assessment possible for people with limited mobility. A study including care-home residents with cognitive or physical impairment found substantial bone fragility and low treatment use in that group. Being able to obtain a bedside measurement does not, by itself, establish its accuracy in every condition associated with disability.

How Closely It Matches DXA

DXA uses low-dose X-rays to measure bone mineral density. It remains the reference method for most osteoporosis diagnosis and treatment monitoring.

In the large European comparison, REMS identified about 90% of women whom DXA classified as having femoral-neck osteoporosis. It agreed with DXA in about 96% of women without that classification. These results came from scans retained after technical quality review.

A 2026 meta-analysis found a strong relationship between REMS and DXA femoral-neck measurements, with substantial variation between studies. Correlation describes whether measurements tend to rise and fall together; two methods can correlate closely while giving meaningfully different results for one person.

Smaller clinical studies have reported weaker agreement. A geriatric study enrolled adults aged 65 and older, with a median age of 75, and REMS missed a substantial share of DXA-defined osteoporosis. Agreement was also limited in a study of people with lupus. In a study of primary and disuse-related osteoporosis, diagnostic agreement was only 13% in the spinal-cord-injury subgroup.

A reassuring REMS result therefore cannot reliably exclude osteoporosis in these groups. The differences between studies also mean that a REMS T-score and a DXA T-score should not be treated as interchangeable measurements.

When DXA and REMS Disagree

DXA can overestimate lumbar-spine density when bone spurs, some vertebral fractures, or nearby arterial calcification affect the image. These are chiefly issues in interpreting the spine, so they do not automatically explain a disagreement between two right-hip measurements.

A study of 70 people found lower lumbar-spine REMS readings than DXA readings in several settings associated with these problems. It did not use an independent reference capable of proving that the lower REMS value was correct in each person. A lower number alone is not evidence that one method is more accurate.

Tracking Your Trend

REMS can produce closely repeatable measurements under controlled conditions. In a study with 37 participants undergoing femoral scans, the same-operator precision error was about 0.32%. That figure describes variation in estimated bone mineral density, not a percentage change in the T-score or the maximum difference between any two scans.

A change needs to exceed the measurement error established for the scanning service before it can confidently be interpreted as biological. Research estimates of the smallest detectable change should not become universal thresholds. Percentage changes should be calculated from bone mineral density, because a T-score is a position relative to a reference distribution.

Repeatability also differs from the ability to detect true change over time. In a small study of people receiving peritoneal dialysis, DXA detected a decline in femoral-neck density that REMS did not detect, and changes measured by the two methods did not correlate. This finding limits confidence in using REMS alone to monitor that population.

When Results Can Be Misleading

  • Incorrect personal details: age, sex, height, and weight contribute to the REMS calculation. A 2026 study experimentally changed entered age and weight while scanning the same volunteers and obtained different density estimates despite unchanged bone.
  • Probe placement and acquisition quality: scan depth, focus, probe angle, and positioning affect the ultrasound signals. Operator training and review of technically inadequate scans matter.
  • Hip surgery or altered anatomy: a hip replacement or other major structural change can limit interpretation using the usual native-hip reference.
  • Different regions or methods: right and left hips, femoral neck and total hip, and REMS and DXA are distinct measurements. Combining them can create an apparent trend.
  • Pregnancy and younger age: pregnancy can involve biological changes in bone, and younger adults generally require age-matched Z-score interpretation rather than diagnosis from a T-score alone.

What Moves This Biomarker

Evidence-backed interventions that affect your REMS T-Score (Right Femur) level

↑ Increase
Alendronate treatment for osteoporosis
Alendronate slows bone breakdown, increases hip bone density, and reduces fracture risk in appropriately selected people with osteoporosis. The randomized evidence measured density with DXA, so it supports the biological benefit without establishing the size of an increase in this REMS T-score.
MedicationModerate Evidence
↓ Decrease
Long-term oral glucocorticoid treatment
Long-term oral glucocorticoids can cause real bone loss and increase fracture risk. Evidence for these effects comes mainly from conventional bone-density measurements and fracture studies; it does not establish a predictable fall in this REMS score. Risk varies with dose, duration, and the condition being treated.
MedicationModerate Evidence
↓ Decrease
Prolonged loss of weight-bearing after spinal cord injury
Loss of normal loading after spinal cord injury can reduce hip bone density. Longitudinal evidence includes DXA measurements showing falling femoral-neck T-scores. REMS can underestimate the severity of bone loss in this population, so it may not accurately capture the biological decline.
LifestyleModerate Evidence
↑ Increase
Denosumab during aromatase-inhibitor treatment for breast cancer
In an observational study, women receiving denosumab had increases in REMS-estimated femoral-neck density over 18 months, while women receiving aromatase inhibitors without osteoporosis medication lost density. Higher estimated density corresponds to a higher T-score when the same reference is used. Treatment was not randomly assigned, so differences between the groups could affect the estimated benefit.
MedicationModest Evidence

Frequently Asked Questions

References

27 studies
  1. G. Adami, G. Arioli, G. Bianchi, M. Brandi, C. Caffarelli, L. Cianferotti, D. Gatti, G. Girasole, S. Gonnelli, M. Manfredini, M. Muratore, E. Quarta, L. QuartaBone2020
  2. B. Cortet, E. Dennison, a. Diez-perez, M. Locquet, M. Muratore, X. Nogués, D. Ovejero Crespo, E. Quarta, M. BrandiBone2021
  3. C. Caffarelli, M. L. Brandi, G. Girasole, a. Giusti, M. Muratore, S. GonnelliCalcified Tissue International2026